Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Depixus has developed and commercialized the MAGNA One instrument, which uses magnetic force spectroscopy to analyze thousands of individual biomolecular interactions in real time. This technology provides direct kinetic and mechanistic data on protein-protein, small molecule-RNA/protein, and other complex biological systems. It enables researchers in academia and industry to accelerate drug discovery—especially for previously undruggable targets—by revealing molecular heterogeneity and dynamics that are not accessible with traditional bulk assays. The company won the SLAS Ignite Award in early 2024 for its innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Depixus.